Documents | Topotecan for the treatment of recurrent and stage IVB cervical cancer | Guidance | NICE

Documents

A list of downloadable documents created during development.

Background information

TA183 Cervical cancer (recurrent) - topotecan: review decision - December 2012 information
Appendix A: decision paper presented to the Institute's Guidance Executive ^{PDF 56.51 KB} 03 December 2012
Cervical cancer (recurrent) - topotecan: review proposal - September 2012 information
Appendix A: provisional matrix of stakeholders ^{PDF 63.58 KB} 10 September 2012
Appendix B: proposal paper presented to the Institute's Guidance Executive ^{PDF 343.5 KB} 10 September 2012

Cervical cancer (recurrent) - topotecan: final appraisal determination

Cervical cancer (recurrent) - topotecan: final appraisal determination information
Cervical cancer (recurrent) - topotecan: final appraisal determination ^{PDF 141.35 KB} 10 September 2009
Response to consultee and commentator comments on the appraisal consultation document ^{PDF 110.47 KB} 10 September 2009
Consultee and commentator comments on the ACD
Department of Health ^{PDF 7.93 KB} 10 September 2009
Royal College of Nursing ^{PDF 20.88 KB} 10 September 2009
GlaxoSmithKline ^{PDF 278.38 KB} 10 September 2009

Cervical cancer (recurrent) - topotecan: appraisal consultation

Cervical cancer (recurrent) - topotecan: appraisal consultation
Cervical cancer (recurrent) - topotecan: appraisal consultations document information
Cervical cancer (recurrent) - topotecan: evaluation report
Pre-meeting briefing ^{PDF 186.17 KB} 17 June 2009
Cervical cancer (recurrent) - topotecan: evidence review group report ^{PDF 875.03 KB} 17 June 2009
NICE clarification letter ^{PDF 473.85 KB} 17 June 2009
Royal College of Nursing ^{PDF 31.21 KB} 17 June 2009
Manufacturer submissions
Manufacturer response to clarification letter ^{PDF 394.85 KB} 17 June 2009
GlaxoSmithKline ^{PDF 1.21 MB} 17 June 2009
Expert written personal statements
Oakley ^{PDF 46.64 KB} 17 June 2009
Pendleton ^{PDF 34.12 KB} 17 June 2009
Symonds ^{PDF 66.52 KB} 17 June 2009
Hirschowitz ^{PDF 34.85 KB} 17 June 2009

Cervical cancer (recurrent) - topotecan: table of comments on draft scope

Cervical cancer (recurrent) - topotecan: table of comments on draft scope ^{PDF 79.56 KB} 09 December 2008

Cervical cancer (recurrent) - topotecan: table of comments on draft matrix

Cervical cancer (recurrent) - topotecan: table of comments on draft matrix ^{PDF 18.69 KB} 09 December 2008

Cervical cancer (recurrent) - topotecan: matrix

Cervical cancer (recurrent) - topotecan: matrix ^{PDF 32 KB} 25 August 2009

Cervical cancer (recurrent) - topotecan: scope

Cervical cancer (recurrent) - topotecan: scope ^{PDF 26.91 KB} 04 December 2008